OGT and QIAGEN Digital Insights (QDI) have announced a partnership that will expand OGT’s bioinformatics capabilities by integrating QIAGEN’s advanced tertiary analysis solution, QCI Interpret, with its SureSeq NGS panels.
Purpose-built for variant interpretation and clinical reporting, QCI Interpret delivers AI-powered, expert-curated classifications along with oncologist-reviewed summaries and transparent evidence links. Through this collaboration, SureSeq NGS panel users gain access to streamlined, high-confidence genomic insights and efficient, scalable reporting from sample to result.
By combining the clinical precision of expert (MD/PhD) curation with the speed and scalability of AI-powered automation, QCI Interpret enables labs to deliver high-confidence variant interpretation and reporting. QCI Interpret empowers SureSeq customers with transparent variant classifications, oncologist-reviewed summaries, and on-demand interpretations—streamlining the path from sequencing to final report.
